Category: Health Science
-
![Bioasis Technologies (BTI.V): To Invest or Not?]()
Bioasis Technologies (BTI.V): To Invest or Not?
For generations, people have suffered from brain cancers, neurodegenerative diseases, and metabolic disorders, and most drugs haven’t been optimized to deliver the right amount of dosage to the brain. One reason for that is the blood-brain barrier. That’s why in this episode, we take a look at Bioasis Technologies (TSX.V: BTI) (OTCQB: BIOAF). Their proprietary…
-
![Bioasis (BTI.V) revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain]()
Bioasis (BTI.V) revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and into the brain
Bioasis is a preclinical biopharmaceutical company focused on research and early-stage development of technologies and products for the treatment of patients with the central nervous system, or CNS, diseases, and disorders. In layman’s terms, this is a company that researches and develops products for the diagnosis and treatment of neurological diseases and disorders. The company…
-
![Bioasis Technologies (BTI.V): First Glance With Jody Vance (Ep 62)]()
Bioasis Technologies (BTI.V): First Glance With Jody Vance (Ep 62)
Dr. Mario Saltarelli, Director of Bioasis Technologies (BTI.V) talks about the company’s ground-breaking xB3 platform which allows therapeutic drugs to pass through the seemingly impenetrable blood-brain barrier, providing an effective treatment methodology for such neurological disorders as Alzheimer’s disease, Lewy Body Dementia and Parkinson’s. In short, Bioasis’ final frontier solution could very well revolutionize medical…
-
![Psyched for this weeks news from CYBN.NE, PSYC.C, MNMD.Q, MSET.C, FTRP.Q, MYCO.NE, RVV.C, FH.NE, CMND.C, ATAI.Q]()
Psyched for this weeks news from CYBN.NE, PSYC.C, MNMD.Q, MSET.C, FTRP.Q, MYCO.NE, RVV.C, FH.NE, CMND.C, ATAI.Q
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been a busy week for Cybin. Last week, after market close, they released their financials for the quarter ending on June 30, 2021, which showed they had…
-
![Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor]()
Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor
Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8 million in cash and cash equivalents. This includes $5 million which was raised through a private placement that closed on June 21. That private placement included…
-
![Filament Health (FH.NEO) Leading the way in Natural Psychedelics. But Is it a Good Long Term Investment?]()
Filament Health (FH.NEO) Leading the way in Natural Psychedelics. But Is it a Good Long Term Investment?
In this episode, we take a look at a company that’s on a mission to get safe, natural psychedelics into the hands of everyone who needs them, as soon as possible. Filament Health (FH.NEO) is an exclusively natural psychedelic drug development company and received the first-ever psilocybin extraction and standardization patent for a public company…
-
![Filament Health (FH.NE): the natural psychedelic company flying under the radar]()
Filament Health (FH.NE): the natural psychedelic company flying under the radar
For the vast majority of the history of human use of psychedelics, they have been seen as something sacred, a gift from God or mother nature herself. Ayahuasca, which contains DMT, was given out by shamans in the Amazon as a tea. It was a spiritual experience that would purge you of your negative energy…
-
![Perimeter (PINK.V) has developed A.I. that radically improves breast cancer surgery outcomes]()
Perimeter (PINK.V) has developed A.I. that radically improves breast cancer surgery outcomes
There is a tendency in our culture to avoid talking about illness. It’s a downer. It’s bad voodoo. Why rattle the cage? But when people do decide to speak bluntly about illness, the reaction is usually positive. “Breast cancer in women has leap-frogged lung cancer, now accounting for the most cancer diagnoses worldwide – and…
-
![Perimeter Medical Imaging (PINK.V) CEO Jeremy Sobotta on Better Breast Cancer Surgery]()
Perimeter Medical Imaging (PINK.V) CEO Jeremy Sobotta on Better Breast Cancer Surgery
Jody Vance, well-known Vancouver-based talk show personality talks with Jeremy Sobotta, Perimeter Medical Imaging (PINK.C) CEO, to get a good look at the company’s mandate of improving the effectiveness of breast cancer surgery by getting everything the first time and how that will impact cancer treatment. We take a look at the technology, the company,…
-
![Perimeter Medical Imaging (PINK.V) stock up over 50% YTD!]()
Perimeter Medical Imaging (PINK.V) stock up over 50% YTD!
Stock Performance Perimeter’s mission is to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address unmet medical needs. The operators have a vision that patients will no longer experience the costly emotional and physical trauma of being called back for a second surgery due to cancer left behind. The company is achieving this…
